Keson-Brookes Maiken
CLO at MURA; CLO & Corp. Secretary at Rubius Therapeutics, Inc.
- Sold, on record
- $561k
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jul 22, 2025
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- MURAMural Oncology plcCLO
- Rubius Therapeutics, Inc.CLO & Corp. Secretary
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Rubius Therapeutics, Inc.27,732 shares
- MURA12,173 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MURARoutineJul 18, 2024 2024
Sold 2,157 shares at $3.41 ($7k)
Keson-Brookes Maiken, Officer
10b5-1 planSold 4.7% of holdings ($157k position)43,850 shares leftFirst sale on recordFiling
- 2 Form 144 notice MURANoticeDec 23, 2024 +158 days
Filed to sell 2,555 shares ($8k)
Keson-Brookes Maiken, CLO
No 10b5-1 planFiling
- 3 Form 4 sale MURARoutineDec 23, 2024 same day
Sold 2,555 shares at $3.27 ($8k)
Keson-Brookes Maiken, Officer
10b5-1 planSold 5.8% of holdings ($143k position)41,295 shares leftFollows a Form 144Filing
- 4 Form 4 sale MURARoutineMar 5, 2025 +72 days
Sold 2,731 shares at $3.41 ($9k)
Keson-Brookes Maiken, Officer
10b5-1 planSold 3.6% of holdings ($260k position)73,564 shares leftFollows a Form 144Filing
- 5 Form 144 notice MURANoticeMar 5, 2025 same day
Filed to sell 1,469 shares ($5k)
Keson-Brookes Maiken, CLO
10b5-1 planFiling
- 6 Form 4 sale MURARoutineJul 18, 2025 +135 days
Sold 2,158 shares at $2.48 ($5k)
Keson-Brookes Maiken, Officer
10b5-1 planSold 2.9% of holdings ($182k position)71,406 shares left0.8x usual sizeFiling
- 7 Form 144 notice MURANoticeJul 22, 2025 +4 days
Filed to sell 2,572 shares ($6k)
Keson-Brookes Maiken, CLO
10b5-1 plan1.1x usual sizeFiling
- 8 Form 4 sale MURARoutineJul 22, 2025 same day
Sold 2,572 shares at $2.48 ($6k)
Keson-Brookes Maiken, Officer
10b5-1 planSold 3.6% of holdings ($177k position)68,834 shares left1.1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 22, 2025 | Jul 23, 2025 | MURA | Officer | Form 4 sale | 2,572 | $6k | 3.6% | Routine | SEC |
| Jul 22, 2025 | Jul 22, 2025 | MURA | CLO | Form 144 notice | 2,572 | $6k | Notice | SEC | |
| Jul 18, 2025 | Jul 22, 2025 | MURA | Officer | Form 4 sale | 2,158 | $5k | 2.9% | Routine | SEC |
| Mar 5, 2025 | Mar 5, 2025 | MURA | CLO | Form 144 notice | 1,469 | $5k | Notice | SEC | |
| Mar 5, 2025 | Mar 5, 2025 | MURA | Officer | Form 4 sale | 2,731 | $9k | 3.6% | Routine | SEC |
| Dec 23, 2024 | Dec 26, 2024 | MURA | Officer | Form 4 sale | 2,555 | $8k | 5.8% | Routine | SEC |
| Dec 23, 2024 | Dec 23, 2024 | MURA | CLO | Form 144 notice | 2,555 | $8k | Notice | SEC | |
| Jul 18, 2024 | Jul 18, 2024 | MURA | Officer | Form 4 sale | 2,157 | $7k | 4.7% | Routine | SEC |
| Feb 1, 2022 | Feb 1, 2022 | Rubius Therapeutics, Inc. | CLO & Corp. Secretary | Form 4 sale | 2,732 | $18k | 33.8% | Unusual | SEC |
| Mar 15, 2021 | Mar 15, 2021 | Rubius Therapeutics, Inc. | CLO & Corp. Secretary | Form 4 sale | 25,000 | $506k | 100.0% | Unusual | SEC |